Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Sundew is a biotechnology company that provides biological services for the treatment of aquatic pests and diseases.
NorFalk is a biotech company that produces bio-based, sustainable surfactants for applications in consumer everyday products.
FÆRM is a food technology company.
Pharmista Technologies is on a mission to revolutionize women’s health by disrupting the pregnancy testing market.
SQALE offers precision fermentation and microalgae businesses Bioprocess Optimization as a service.
PreTT is revolutionizing the treatment of cancer by using sophisticated radioligand therapies that outperform conventional techniques.
Polyceutix transforms cancer treatment by unleashing the full power of the immune system.
SNL Biosolutions created a technological platform to decrease deforestation and manufacture fermented-based oils on a large scale.
SymbioMatch mission is to grow healthier plants using AI for tailored biostimulants with less fertilizers used.
Oasicare creates medical devices to help prevent severe perineal tears and OASI during vaginal childbirth.
FimmCyte is a biotechnology company that engages in the research and treatment of chronic endometriosis disease.
First-in-class hardware-and-software-as-a-service diagnostics for the 400M suffering from middle ear problems
Notify Therapeutics develops therapies for the treatment of infertility.
Solid Therapeutics develops novel cancer therapeutics with dual performance targeting cancer cells and immune cells to treat solid tumors.
TriptoBIO is a biotechnology research company developing a platform for producing natural plant compounds.
Amalus Therapeutics' objective is to significantly improve the lives of those suffering from cancer and fibrotic disorders
BioHalo is transforming the halogenated chemicals industry by developing more sustainable and bio-based fluorinated polymers.
MedicQuant is a medical equipment manufacturing company developing diagnostic kits for blood anticoagulant properties.
MELLO develops probiotic delivery technology to enhance the effective delivery of probiotics.
Amplify Therapeutics is dedicated to the development of transformative, disease-modifying therapies for Gaucher disease.
Kesmalea Therapeutics is a biotech startup focusing on the discovery of novel protein degraders.
Breye Therapeutics, a biopharmaceutical firm that provide cutting-edge oral treatments for the management of retinal vascular diseases.
Upstream Foods is developing a novel fat ingredient to uplevel seafood alternatives
Heka VR is a virtual reality platform developing a novel therapy to aid people suffering from auditory hallucinations.
BioInnovation Institute has invested in 157 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
BioInnovation Institute's top investment sectors include Biotechnology, Medical, Health Care, Biopharma, Medical Device. The firm invests across 25 different industry categories.
Among tracked funding rounds, Kesmalea Therapeutics received $6.0M in a Series A round. BioInnovation Institute's total known invested capital is $402.9M.
BioInnovation Institute's average investment size is $3.6M across its portfolio of 157 companies.
Recent BioInnovation Institute portfolio additions include Sundew, NorFalk, FÆRM, Pharmista Technologies, Sqale. These companies were founded in 2020 or later.